Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Telomere | 77 | 2024 | 943 | 8.720 |
Why?
|
Endometrial Neoplasms | 66 | 2025 | 1382 | 8.510 |
Why?
|
Leukocytes | 51 | 2024 | 2030 | 4.640 |
Why?
|
Genetic Predisposition to Disease | 80 | 2023 | 18047 | 1.810 |
Why?
|
Polymorphism, Genetic | 34 | 2015 | 4250 | 1.770 |
Why?
|
Polymorphism, Single Nucleotide | 77 | 2024 | 16027 | 1.530 |
Why?
|
Genome-Wide Association Study | 48 | 2024 | 12775 | 1.370 |
Why?
|
Case-Control Studies | 108 | 2025 | 22292 | 1.330 |
Why?
|
Telomerase | 10 | 2023 | 752 | 1.250 |
Why?
|
DNA, Mitochondrial | 11 | 2023 | 871 | 1.140 |
Why?
|
Aging | 26 | 2024 | 8764 | 1.050 |
Why?
|
Receptors, Progesterone | 6 | 2017 | 1145 | 1.000 |
Why?
|
Nurses | 19 | 2017 | 2494 | 0.920 |
Why?
|
Urinary Bladder Neoplasms | 16 | 2023 | 2256 | 0.870 |
Why?
|
Body Mass Index | 27 | 2025 | 13050 | 0.830 |
Why?
|
DNA Copy Number Variations | 11 | 2023 | 2046 | 0.820 |
Why?
|
Genotype | 53 | 2024 | 13038 | 0.810 |
Why?
|
Adenocarcinoma | 10 | 2016 | 6404 | 0.790 |
Why?
|
Risk Factors | 113 | 2025 | 74954 | 0.750 |
Why?
|
Middle Aged | 176 | 2025 | 223463 | 0.740 |
Why?
|
Glutathione Transferase | 5 | 2011 | 564 | 0.710 |
Why?
|
Female | 235 | 2025 | 397050 | 0.710 |
Why?
|
Ovarian Neoplasms | 16 | 2023 | 4908 | 0.700 |
Why?
|
Glucuronosyltransferase | 5 | 2012 | 136 | 0.670 |
Why?
|
Alleles | 30 | 2021 | 6892 | 0.670 |
Why?
|
Carbon | 2 | 2013 | 672 | 0.650 |
Why?
|
DNA Methylation | 15 | 2024 | 4419 | 0.620 |
Why?
|
Estradiol | 9 | 2012 | 1952 | 0.620 |
Why?
|
Humans | 294 | 2025 | 768298 | 0.600 |
Why?
|
Genetic Loci | 10 | 2017 | 2630 | 0.600 |
Why?
|
Arylamine N-Acetyltransferase | 4 | 2023 | 87 | 0.570 |
Why?
|
Coffee | 3 | 2020 | 597 | 0.570 |
Why?
|
Genetic Variation | 18 | 2021 | 6606 | 0.570 |
Why?
|
Adult | 142 | 2025 | 223622 | 0.570 |
Why?
|
Smoking | 25 | 2025 | 9109 | 0.560 |
Why?
|
Postmenopause | 8 | 2012 | 2518 | 0.550 |
Why?
|
Vitamin D | 4 | 2015 | 3311 | 0.550 |
Why?
|
Diet | 14 | 2023 | 8097 | 0.550 |
Why?
|
Aromatase | 6 | 2009 | 147 | 0.510 |
Why?
|
Paternal Age | 2 | 2012 | 87 | 0.500 |
Why?
|
Diet, Mediterranean | 3 | 2020 | 747 | 0.500 |
Why?
|
Prospective Studies | 69 | 2023 | 54921 | 0.500 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 362 | 0.490 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 5 | 2008 | 246 | 0.490 |
Why?
|
Haplotypes | 12 | 2014 | 2724 | 0.460 |
Why?
|
Aged | 99 | 2025 | 171544 | 0.450 |
Why?
|
Menarche | 4 | 2025 | 538 | 0.440 |
Why?
|
Gene Frequency | 13 | 2024 | 3615 | 0.440 |
Why?
|
Skin Neoplasms | 13 | 2020 | 5857 | 0.430 |
Why?
|
Metabolic Networks and Pathways | 3 | 2017 | 798 | 0.430 |
Why?
|
Phobic Disorders | 3 | 2018 | 441 | 0.420 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2012 | 554 | 0.420 |
Why?
|
Talc | 2 | 2010 | 48 | 0.410 |
Why?
|
Carcinoma, Basal Cell | 6 | 2016 | 562 | 0.410 |
Why?
|
Breast Neoplasms | 22 | 2015 | 21163 | 0.400 |
Why?
|
Catechol O-Methyltransferase | 2 | 2004 | 251 | 0.390 |
Why?
|
Caffeine | 5 | 2020 | 702 | 0.390 |
Why?
|
Risk | 19 | 2024 | 9635 | 0.380 |
Why?
|
Social Class | 4 | 2023 | 2008 | 0.370 |
Why?
|
Estradiol Dehydrogenases | 1 | 2010 | 16 | 0.370 |
Why?
|
Endometriosis | 4 | 2023 | 875 | 0.370 |
Why?
|
Cohort Studies | 47 | 2024 | 41791 | 0.360 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2010 | 58 | 0.360 |
Why?
|
Hydro-Lyases | 1 | 2010 | 94 | 0.360 |
Why?
|
Arthritis, Rheumatoid | 6 | 2016 | 3776 | 0.360 |
Why?
|
Life Change Events | 3 | 2024 | 962 | 0.360 |
Why?
|
Vitamin B Complex | 1 | 2013 | 299 | 0.360 |
Why?
|
Cross-Sectional Studies | 24 | 2024 | 26373 | 0.360 |
Why?
|
Estrone | 6 | 2010 | 234 | 0.350 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2011 | 126 | 0.350 |
Why?
|
Cholesterol Side-Chain Cleavage Enzyme | 1 | 2010 | 28 | 0.350 |
Why?
|
Polymerase Chain Reaction | 15 | 2016 | 6084 | 0.350 |
Why?
|
Menopause | 9 | 2024 | 1653 | 0.350 |
Why?
|
Body Height | 3 | 2023 | 1568 | 0.340 |
Why?
|
Puberty | 3 | 2024 | 502 | 0.340 |
Why?
|
Reproduction | 3 | 2015 | 646 | 0.330 |
Why?
|
Obesity | 14 | 2023 | 13082 | 0.330 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2011 | 268 | 0.330 |
Why?
|
Life Style | 8 | 2021 | 3930 | 0.320 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2011 | 415 | 0.320 |
Why?
|
Leiomyoma | 3 | 2010 | 644 | 0.320 |
Why?
|
Epigenesis, Genetic | 8 | 2024 | 3826 | 0.320 |
Why?
|
Perineum | 1 | 2010 | 210 | 0.310 |
Why?
|
Estrogen Replacement Therapy | 4 | 2010 | 1209 | 0.310 |
Why?
|
Temperament | 2 | 2023 | 301 | 0.310 |
Why?
|
Hyperinsulinism | 2 | 2023 | 401 | 0.310 |
Why?
|
Logistic Models | 23 | 2023 | 13323 | 0.310 |
Why?
|
Antioxidants | 5 | 2021 | 1673 | 0.310 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2247 | 0.310 |
Why?
|
Neoplasms | 12 | 2023 | 22389 | 0.310 |
Why?
|
Carotenoids | 4 | 2007 | 621 | 0.300 |
Why?
|
Uterine Neoplasms | 4 | 2013 | 1426 | 0.300 |
Why?
|
Melanoma | 7 | 2020 | 5705 | 0.290 |
Why?
|
Male | 104 | 2024 | 364870 | 0.280 |
Why?
|
Pancreatic Neoplasms | 7 | 2021 | 5443 | 0.280 |
Why?
|
Maternal Exposure | 3 | 2019 | 1079 | 0.280 |
Why?
|
DNA | 8 | 2022 | 7211 | 0.280 |
Why?
|
Gene Dosage | 4 | 2016 | 1221 | 0.280 |
Why?
|
Epigenomics | 3 | 2024 | 959 | 0.280 |
Why?
|
Exercise | 3 | 2020 | 5947 | 0.270 |
Why?
|
Nevus | 2 | 2020 | 205 | 0.270 |
Why?
|
Nutritional Status | 3 | 2018 | 1627 | 0.270 |
Why?
|
Odds Ratio | 18 | 2025 | 9681 | 0.270 |
Why?
|
Isoenzymes | 3 | 2006 | 1684 | 0.270 |
Why?
|
Epidemiologic Methods | 1 | 2011 | 1337 | 0.270 |
Why?
|
Diet Records | 4 | 2016 | 427 | 0.270 |
Why?
|
Receptors, Androgen | 4 | 2009 | 1083 | 0.270 |
Why?
|
GATA5 Transcription Factor | 1 | 2006 | 18 | 0.270 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 83 | 0.260 |
Why?
|
Vitamin B 12 | 2 | 2023 | 527 | 0.260 |
Why?
|
Oxidative Stress | 10 | 2023 | 3139 | 0.250 |
Why?
|
Models, Genetic | 6 | 2020 | 3442 | 0.250 |
Why?
|
Genes, p53 | 3 | 2007 | 715 | 0.250 |
Why?
|
Research Design | 3 | 2022 | 6209 | 0.250 |
Why?
|
Mitochondria | 5 | 2023 | 3675 | 0.250 |
Why?
|
Women's Health | 8 | 2019 | 2078 | 0.240 |
Why?
|
Incidence | 15 | 2024 | 21544 | 0.240 |
Why?
|
Multifactorial Inheritance | 4 | 2024 | 1421 | 0.240 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2005 | 190 | 0.230 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2004 | 30 | 0.230 |
Why?
|
Androgens | 2 | 2009 | 1285 | 0.230 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2007 | 2889 | 0.230 |
Why?
|
Stress Disorders, Post-Traumatic | 7 | 2018 | 4637 | 0.230 |
Why?
|
Longevity | 3 | 2021 | 1077 | 0.230 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2004 | 767 | 0.230 |
Why?
|
United States | 41 | 2025 | 73144 | 0.230 |
Why?
|
Amino Acid Substitution | 3 | 2004 | 1743 | 0.220 |
Why?
|
Insulin Resistance | 1 | 2018 | 3981 | 0.220 |
Why?
|
Dietary Supplements | 3 | 2023 | 3443 | 0.220 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2022 | 1376 | 0.220 |
Why?
|
Phenol | 1 | 2023 | 44 | 0.220 |
Why?
|
Genetic Association Studies | 6 | 2016 | 2741 | 0.210 |
Why?
|
Testosterone | 2 | 2012 | 2493 | 0.210 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2022 | 1398 | 0.210 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2011 | 1943 | 0.210 |
Why?
|
Age Factors | 16 | 2025 | 18472 | 0.210 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2004 | 276 | 0.210 |
Why?
|
Sequence Analysis, DNA | 5 | 2018 | 4774 | 0.210 |
Why?
|
Depression | 7 | 2020 | 8241 | 0.210 |
Why?
|
Proportional Hazards Models | 9 | 2020 | 12557 | 0.200 |
Why?
|
Petroleum | 1 | 2022 | 81 | 0.200 |
Why?
|
Confidence Intervals | 7 | 2013 | 2931 | 0.200 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2019 | 1658 | 0.200 |
Why?
|
Steroid 17-alpha-Hydroxylase | 2 | 2003 | 99 | 0.200 |
Why?
|
Mosaicism | 2 | 2016 | 481 | 0.200 |
Why?
|
Follow-Up Studies | 22 | 2023 | 39405 | 0.200 |
Why?
|
DNA Damage | 4 | 2021 | 2459 | 0.200 |
Why?
|
Phenols | 2 | 2023 | 520 | 0.190 |
Why?
|
Mendelian Randomization Analysis | 3 | 2022 | 1037 | 0.190 |
Why?
|
PPAR gamma | 1 | 2004 | 487 | 0.190 |
Why?
|
Germ-Line Mutation | 3 | 2017 | 1885 | 0.190 |
Why?
|
Environment | 2 | 2023 | 1125 | 0.190 |
Why?
|
Least-Squares Analysis | 2 | 2012 | 368 | 0.190 |
Why?
|
Diet Surveys | 2 | 2016 | 1161 | 0.180 |
Why?
|
Myelodysplastic Syndromes | 2 | 2021 | 1399 | 0.180 |
Why?
|
Phosphoproteins | 1 | 2010 | 2448 | 0.180 |
Why?
|
Gonadal Steroid Hormones | 2 | 2017 | 708 | 0.180 |
Why?
|
Anxiety Disorders | 1 | 2012 | 2754 | 0.180 |
Why?
|
Insulin | 2 | 2020 | 6608 | 0.180 |
Why?
|
Barrett Esophagus | 2 | 2019 | 494 | 0.180 |
Why?
|
Risk Assessment | 14 | 2020 | 24316 | 0.180 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2003 | 339 | 0.180 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2011 | 247 | 0.180 |
Why?
|
DNA Repair | 5 | 2021 | 2050 | 0.180 |
Why?
|
Urogenital Neoplasms | 1 | 2021 | 133 | 0.180 |
Why?
|
Apolipoprotein E4 | 2 | 2024 | 711 | 0.180 |
Why?
|
Cognition | 4 | 2024 | 7074 | 0.170 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2002 | 423 | 0.170 |
Why?
|
Triclosan | 1 | 2019 | 58 | 0.160 |
Why?
|
Mutation, Missense | 3 | 2009 | 2593 | 0.160 |
Why?
|
Osteosarcoma | 2 | 2023 | 911 | 0.160 |
Why?
|
Membrane Proteins | 6 | 2023 | 7885 | 0.160 |
Why?
|
Longitudinal Studies | 14 | 2023 | 14783 | 0.160 |
Why?
|
Occupational Diseases | 4 | 2014 | 1490 | 0.160 |
Why?
|
Ovary | 2 | 2021 | 960 | 0.160 |
Why?
|
Phosphoric Monoester Hydrolases | 2 | 2000 | 413 | 0.160 |
Why?
|
Cholecalciferol | 1 | 2024 | 557 | 0.160 |
Why?
|
Occupational Exposure | 3 | 2021 | 1817 | 0.150 |
Why?
|
Linkage Disequilibrium | 9 | 2016 | 1998 | 0.150 |
Why?
|
Siblings | 2 | 2020 | 829 | 0.150 |
Why?
|
Astronauts | 1 | 2019 | 93 | 0.150 |
Why?
|
Flavonols | 1 | 2018 | 84 | 0.150 |
Why?
|
Vinyl Chloride | 2 | 1996 | 15 | 0.150 |
Why?
|
Cholesterol, HDL | 3 | 2022 | 1820 | 0.150 |
Why?
|
Inflammation | 8 | 2023 | 10863 | 0.150 |
Why?
|
DNA-Binding Proteins | 8 | 2014 | 9618 | 0.150 |
Why?
|
Receptors, Adiponectin | 1 | 2018 | 82 | 0.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2018 | 8628 | 0.150 |
Why?
|
Colorectal Neoplasms | 4 | 2022 | 6969 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1135 | 0.140 |
Why?
|
Folic Acid | 4 | 2013 | 1336 | 0.140 |
Why?
|
Cacao | 1 | 2018 | 98 | 0.140 |
Why?
|
Cell Survival | 2 | 2023 | 5792 | 0.140 |
Why?
|
Aged, 80 and over | 19 | 2024 | 59683 | 0.140 |
Why?
|
Ribonucleoproteins | 2 | 2017 | 359 | 0.140 |
Why?
|
Cooking | 2 | 2022 | 312 | 0.140 |
Why?
|
Estrogens | 4 | 2015 | 1534 | 0.140 |
Why?
|
Particulate Matter | 4 | 2018 | 2609 | 0.140 |
Why?
|
Prognosis | 14 | 2020 | 30020 | 0.140 |
Why?
|
Smoke | 1 | 2019 | 236 | 0.140 |
Why?
|
Health Surveys | 6 | 2020 | 4056 | 0.140 |
Why?
|
Stress, Psychological | 4 | 2024 | 4543 | 0.140 |
Why?
|
Chromosomes, Human, Pair 22 | 2 | 2010 | 348 | 0.140 |
Why?
|
Arachidonic Acid | 1 | 2018 | 429 | 0.140 |
Why?
|
Apoptosis | 4 | 2009 | 9506 | 0.140 |
Why?
|
Life Expectancy | 1 | 2023 | 1249 | 0.130 |
Why?
|
N-Glycosyl Hydrolases | 1 | 2016 | 68 | 0.130 |
Why?
|
Endocrine Disruptors | 1 | 2019 | 264 | 0.130 |
Why?
|
Space Flight | 1 | 2019 | 218 | 0.130 |
Why?
|
Receptors, Leptin | 1 | 2018 | 350 | 0.130 |
Why?
|
Residence Characteristics | 3 | 2023 | 2122 | 0.130 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 3242 | 0.130 |
Why?
|
Retinoid X Receptor alpha | 1 | 2015 | 22 | 0.130 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2000 | 594 | 0.130 |
Why?
|
DNA, Neoplasm | 5 | 2012 | 1748 | 0.130 |
Why?
|
Alcohol Drinking | 4 | 2020 | 4049 | 0.130 |
Why?
|
Disease-Free Survival | 4 | 2021 | 6856 | 0.130 |
Why?
|
Anesthetics, Inhalation | 1 | 2021 | 573 | 0.130 |
Why?
|
Genes, Tumor Suppressor | 1 | 2000 | 1064 | 0.130 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2016 | 127 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2021 | 12239 | 0.130 |
Why?
|
Fertilization in Vitro | 1 | 2003 | 1302 | 0.120 |
Why?
|
Population Groups | 1 | 2016 | 208 | 0.120 |
Why?
|
Chromosomes, Human, Pair 5 | 2 | 2014 | 387 | 0.120 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2016 | 192 | 0.120 |
Why?
|
Homocysteine | 1 | 2018 | 637 | 0.120 |
Why?
|
ROC Curve | 1 | 2023 | 3622 | 0.120 |
Why?
|
Birth Weight | 1 | 2023 | 2114 | 0.120 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 9508 | 0.120 |
Why?
|
Air Pollution, Indoor | 1 | 2022 | 915 | 0.120 |
Why?
|
Depressive Disorder, Major | 4 | 2018 | 4819 | 0.120 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2016 | 370 | 0.120 |
Why?
|
Estrogen Receptor alpha | 2 | 2017 | 580 | 0.120 |
Why?
|
Phthalic Acids | 1 | 2019 | 484 | 0.120 |
Why?
|
Carcinogens | 2 | 2012 | 455 | 0.120 |
Why?
|
Memory | 1 | 2024 | 2210 | 0.120 |
Why?
|
Eicosapentaenoic Acid | 1 | 2018 | 563 | 0.120 |
Why?
|
Estrogen Receptor beta | 1 | 2015 | 171 | 0.120 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2398 | 0.120 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2014 | 50 | 0.120 |
Why?
|
Genome, Human | 3 | 2015 | 4450 | 0.120 |
Why?
|
Menstrual Cycle | 2 | 2015 | 545 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2011 | 1151 | 0.110 |
Why?
|
Phenotype | 9 | 2020 | 16716 | 0.110 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 320 | 0.110 |
Why?
|
Pilot Projects | 5 | 2023 | 8730 | 0.110 |
Why?
|
Cyclin E | 1 | 2014 | 156 | 0.110 |
Why?
|
Vesicular Monoamine Transport Proteins | 1 | 2014 | 33 | 0.110 |
Why?
|
Tumor Burden | 1 | 2020 | 1913 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2016 | 4069 | 0.110 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 229 | 0.110 |
Why?
|
MicroRNAs | 2 | 2022 | 3794 | 0.110 |
Why?
|
Caregivers | 2 | 2018 | 2303 | 0.110 |
Why?
|
Apolipoproteins E | 3 | 2024 | 1459 | 0.110 |
Why?
|
Receptor, Insulin | 1 | 2018 | 838 | 0.110 |
Why?
|
Transplantation Conditioning | 1 | 2020 | 1600 | 0.110 |
Why?
|
Work Schedule Tolerance | 2 | 2023 | 553 | 0.110 |
Why?
|
Body Fat Distribution | 1 | 2015 | 246 | 0.110 |
Why?
|
Triglycerides | 2 | 2020 | 2465 | 0.110 |
Why?
|
Casein Kinase II | 1 | 2014 | 121 | 0.110 |
Why?
|
Genes, ras | 3 | 2008 | 665 | 0.110 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 93 | 0.110 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2014 | 350 | 0.110 |
Why?
|
Gallstones | 1 | 2016 | 285 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 945 | 0.110 |
Why?
|
Health Behavior | 2 | 2016 | 2647 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15455 | 0.110 |
Why?
|
Welding | 1 | 2014 | 89 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1855 | 0.110 |
Why?
|
Europe | 6 | 2021 | 3439 | 0.110 |
Why?
|
Saliva | 2 | 2015 | 854 | 0.110 |
Why?
|
Dementia | 1 | 2008 | 2728 | 0.110 |
Why?
|
Intrauterine Devices | 1 | 2014 | 117 | 0.110 |
Why?
|
Epidemiologic Studies | 4 | 2018 | 678 | 0.110 |
Why?
|
Antigens, CD | 2 | 2018 | 4031 | 0.110 |
Why?
|
Mutagens | 1 | 2014 | 181 | 0.110 |
Why?
|
Polycyclic Compounds | 1 | 1992 | 29 | 0.110 |
Why?
|
Adolescent | 19 | 2024 | 89182 | 0.110 |
Why?
|
Mixed Tumor, Mullerian | 1 | 2013 | 55 | 0.100 |
Why?
|
Love | 1 | 2013 | 40 | 0.100 |
Why?
|
Intestinal Polyps | 1 | 1993 | 105 | 0.100 |
Why?
|
Anemia, Aplastic | 1 | 2015 | 231 | 0.100 |
Why?
|
Hemangiosarcoma | 2 | 1996 | 216 | 0.100 |
Why?
|
Genetic Markers | 4 | 2023 | 2604 | 0.100 |
Why?
|
Critical Pathways | 1 | 2016 | 476 | 0.100 |
Why?
|
Carcinogens, Environmental | 1 | 1992 | 71 | 0.100 |
Why?
|
Cause of Death | 3 | 2020 | 3728 | 0.100 |
Why?
|
Child Abuse, Sexual | 1 | 2015 | 404 | 0.100 |
Why?
|
Disabled Children | 1 | 2014 | 251 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2020 | 1601 | 0.100 |
Why?
|
Vitamin D-Binding Protein | 1 | 2013 | 130 | 0.100 |
Why?
|
Adaptation, Physiological | 1 | 2019 | 1315 | 0.100 |
Why?
|
Genomic Instability | 2 | 2019 | 715 | 0.100 |
Why?
|
Child Development | 2 | 2023 | 2334 | 0.100 |
Why?
|
Nepal | 2 | 2023 | 301 | 0.100 |
Why?
|
Adiponectin | 1 | 2018 | 1117 | 0.100 |
Why?
|
Genomic Imprinting | 3 | 2017 | 324 | 0.100 |
Why?
|
Alzheimer Disease | 2 | 2024 | 8747 | 0.100 |
Why?
|
Vitamin B 6 | 1 | 2013 | 234 | 0.100 |
Why?
|
Cell Division | 2 | 1998 | 4478 | 0.100 |
Why?
|
Spinal Cord Injuries | 1 | 2019 | 929 | 0.100 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2011 | 22 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 4 | 2014 | 4526 | 0.090 |
Why?
|
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2011 | 53 | 0.090 |
Why?
|
Occupations | 1 | 2014 | 519 | 0.090 |
Why?
|
Prostatic Neoplasms | 4 | 2023 | 11220 | 0.090 |
Why?
|
Socioeconomic Factors | 6 | 2024 | 7861 | 0.090 |
Why?
|
Sex Factors | 4 | 2020 | 10656 | 0.090 |
Why?
|
Cell Proliferation | 2 | 2023 | 10464 | 0.090 |
Why?
|
Chromosome Aberrations | 2 | 2015 | 1780 | 0.090 |
Why?
|
Premenopause | 3 | 2008 | 1039 | 0.090 |
Why?
|
Depressive Disorder | 3 | 2019 | 3736 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2014 | 3609 | 0.090 |
Why?
|
Infant, Premature | 1 | 2021 | 2125 | 0.090 |
Why?
|
Choline | 1 | 2013 | 518 | 0.090 |
Why?
|
Inhalation Exposure | 1 | 2014 | 431 | 0.090 |
Why?
|
Neoplasms, Basal Cell | 1 | 2010 | 30 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2014 | 1605 | 0.090 |
Why?
|
Receptors, Calcitriol | 1 | 2013 | 361 | 0.090 |
Why?
|
Psychosocial Deprivation | 1 | 2011 | 101 | 0.090 |
Why?
|
Methionine | 1 | 2013 | 573 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 2014 | 718 | 0.090 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2011 | 131 | 0.090 |
Why?
|
Carcinoma, Endometrioid | 1 | 2013 | 276 | 0.090 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2010 | 95 | 0.090 |
Why?
|
Hypothalamus | 1 | 2015 | 1005 | 0.090 |
Why?
|
Gene Expression | 2 | 2021 | 7595 | 0.090 |
Why?
|
Neoplasm Invasiveness | 4 | 2015 | 3631 | 0.090 |
Why?
|
Environmental Pollutants | 1 | 2019 | 1290 | 0.090 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 710 | 0.090 |
Why?
|
Young Adult | 15 | 2025 | 60048 | 0.090 |
Why?
|
Child, Institutionalized | 1 | 2011 | 111 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2000 | 2811 | 0.080 |
Why?
|
Cognition Disorders | 3 | 2011 | 3985 | 0.080 |
Why?
|
Meditation | 1 | 2013 | 257 | 0.080 |
Why?
|
Anesthesia | 1 | 2021 | 1596 | 0.080 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.080 |
Why?
|
Probability | 2 | 2021 | 2482 | 0.080 |
Why?
|
Quantitative Trait Loci | 4 | 2020 | 2127 | 0.080 |
Why?
|
Maternal Age | 1 | 2012 | 809 | 0.080 |
Why?
|
Reference Values | 3 | 2007 | 4941 | 0.080 |
Why?
|
Linear Models | 3 | 2017 | 5878 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2016 | 945 | 0.080 |
Why?
|
Glaucoma, Open-Angle | 1 | 2016 | 742 | 0.080 |
Why?
|
Lung Neoplasms | 8 | 2020 | 13576 | 0.080 |
Why?
|
Nails | 2 | 2014 | 297 | 0.080 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1158 | 0.080 |
Why?
|
Breast Feeding | 1 | 2017 | 1364 | 0.080 |
Why?
|
Kv1.5 Potassium Channel | 1 | 2008 | 5 | 0.080 |
Why?
|
Resilience, Psychological | 1 | 2016 | 804 | 0.080 |
Why?
|
Codon | 2 | 2004 | 599 | 0.080 |
Why?
|
Parturition | 1 | 2012 | 453 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1622 | 0.080 |
Why?
|
Rhodopsin | 1 | 2009 | 198 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 379 | 0.080 |
Why?
|
Anthropometry | 2 | 2016 | 1343 | 0.080 |
Why?
|
Carrier Proteins | 2 | 1998 | 4940 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20224 | 0.080 |
Why?
|
Infant | 9 | 2023 | 36512 | 0.080 |
Why?
|
Perception | 1 | 2014 | 1206 | 0.080 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 607 | 0.070 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2008 | 64 | 0.070 |
Why?
|
Hormones | 2 | 2003 | 870 | 0.070 |
Why?
|
Child | 14 | 2024 | 80894 | 0.070 |
Why?
|
Adiposity | 1 | 2018 | 1895 | 0.070 |
Why?
|
Colonic Polyps | 1 | 1993 | 557 | 0.070 |
Why?
|
Contraceptives, Oral | 2 | 2025 | 562 | 0.070 |
Why?
|
Calcium | 2 | 2013 | 5794 | 0.070 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2009 | 534 | 0.070 |
Why?
|
Base Sequence | 4 | 2009 | 12421 | 0.070 |
Why?
|
Hydrolases | 1 | 2008 | 146 | 0.070 |
Why?
|
Cell Growth Processes | 1 | 2008 | 381 | 0.070 |
Why?
|
Parents | 3 | 2020 | 3596 | 0.070 |
Why?
|
Carcinoma in Situ | 1 | 2013 | 789 | 0.070 |
Why?
|
Disease Susceptibility | 2 | 2004 | 1795 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2257 | 0.070 |
Why?
|
Prolactin | 1 | 2009 | 626 | 0.070 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2008 | 297 | 0.070 |
Why?
|
Metabolomics | 1 | 2016 | 1675 | 0.070 |
Why?
|
Neoplasm Staging | 5 | 2013 | 11254 | 0.070 |
Why?
|
Ethanol | 1 | 2013 | 1333 | 0.070 |
Why?
|
Parity | 2 | 2025 | 938 | 0.070 |
Why?
|
Promoter Regions, Genetic | 4 | 2006 | 5800 | 0.070 |
Why?
|
Venous Thromboembolism | 2 | 2017 | 1881 | 0.070 |
Why?
|
Alanine | 2 | 2009 | 613 | 0.070 |
Why?
|
Environmental Exposure | 2 | 2019 | 4528 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 1994 | 1765 | 0.070 |
Why?
|
CpG Islands | 2 | 2022 | 1208 | 0.060 |
Why?
|
NFATC Transcription Factors | 1 | 2008 | 393 | 0.060 |
Why?
|
Child, Preschool | 8 | 2023 | 42654 | 0.060 |
Why?
|
Membrane Transport Proteins | 1 | 2011 | 1034 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2008 | 720 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 2 | 2014 | 3407 | 0.060 |
Why?
|
Regression Analysis | 3 | 2014 | 6350 | 0.060 |
Why?
|
Retinitis Pigmentosa | 1 | 2009 | 395 | 0.060 |
Why?
|
Sex Characteristics | 4 | 2024 | 2661 | 0.060 |
Why?
|
Tissue Donors | 1 | 2015 | 2389 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 1998 | 4785 | 0.060 |
Why?
|
Self Report | 2 | 2018 | 3766 | 0.060 |
Why?
|
Meta-Analysis as Topic | 3 | 2014 | 1364 | 0.060 |
Why?
|
Animals | 12 | 2024 | 169322 | 0.060 |
Why?
|
Androstenedione | 1 | 2004 | 132 | 0.060 |
Why?
|
Body Size | 1 | 2007 | 463 | 0.060 |
Why?
|
Stromal Cells | 1 | 2010 | 1337 | 0.060 |
Why?
|
Neuroendocrine Tumors | 1 | 2011 | 657 | 0.060 |
Why?
|
Air Pollution | 1 | 2018 | 2363 | 0.060 |
Why?
|
Survival Rate | 4 | 2021 | 12870 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 1906 | 0.060 |
Why?
|
Flavonoids | 1 | 2007 | 447 | 0.060 |
Why?
|
Estrogens, Catechol | 1 | 2004 | 25 | 0.060 |
Why?
|
Glucuronides | 1 | 2004 | 20 | 0.060 |
Why?
|
Trinucleotide Repeats | 1 | 2005 | 257 | 0.060 |
Why?
|
Air Pollutants | 1 | 2018 | 2900 | 0.060 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2008 | 489 | 0.060 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2006 | 294 | 0.060 |
Why?
|
Hypertension | 1 | 2024 | 8615 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 1993 | 1185 | 0.060 |
Why?
|
Proteins | 3 | 2014 | 6006 | 0.060 |
Why?
|
Ketone Bodies | 1 | 2023 | 76 | 0.060 |
Why?
|
Lung | 3 | 2022 | 10087 | 0.050 |
Why?
|
Puberty, Delayed | 1 | 2024 | 124 | 0.050 |
Why?
|
RNA | 1 | 2013 | 2726 | 0.050 |
Why?
|
Genomics | 2 | 2016 | 5916 | 0.050 |
Why?
|
Hypertriglyceridemia | 1 | 2006 | 293 | 0.050 |
Why?
|
Anxiety | 1 | 2018 | 4675 | 0.050 |
Why?
|
Leucine | 1 | 2004 | 548 | 0.050 |
Why?
|
Acetaminophen | 1 | 2007 | 556 | 0.050 |
Why?
|
Pregnancy | 7 | 2020 | 30198 | 0.050 |
Why?
|
Mutation | 6 | 2017 | 30230 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2019 | 10377 | 0.050 |
Why?
|
Neuropsychological Tests | 3 | 2024 | 7145 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2011 | 2846 | 0.050 |
Why?
|
Valine | 1 | 2004 | 410 | 0.050 |
Why?
|
Puberty, Precocious | 1 | 2024 | 166 | 0.050 |
Why?
|
Organ Size | 1 | 2008 | 2268 | 0.050 |
Why?
|
Selenium | 1 | 2005 | 418 | 0.050 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2023 | 119 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2023 | 12457 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2021 | 26410 | 0.050 |
Why?
|
Health Resources | 1 | 2009 | 950 | 0.050 |
Why?
|
Australia | 3 | 2012 | 1265 | 0.050 |
Why?
|
Poland | 2 | 2012 | 197 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2002 | 125 | 0.050 |
Why?
|
beta Carotene | 1 | 2003 | 523 | 0.050 |
Why?
|
Adenoma | 1 | 1993 | 2163 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2008 | 17132 | 0.050 |
Why?
|
Fertility | 2 | 2021 | 772 | 0.050 |
Why?
|
Sleep | 2 | 2023 | 4802 | 0.050 |
Why?
|
Cardiovascular Diseases | 4 | 2017 | 15652 | 0.050 |
Why?
|
Educational Status | 2 | 2024 | 2518 | 0.050 |
Why?
|
Massachusetts | 5 | 2015 | 8902 | 0.050 |
Why?
|
Motor Activity | 1 | 2012 | 2720 | 0.050 |
Why?
|
Age Distribution | 1 | 2007 | 2877 | 0.050 |
Why?
|
Liver Neoplasms | 2 | 1996 | 4360 | 0.050 |
Why?
|
Embryo Implantation | 1 | 2003 | 272 | 0.050 |
Why?
|
Sarcoma | 1 | 2013 | 1806 | 0.050 |
Why?
|
Personality Inventory | 1 | 2004 | 1018 | 0.050 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2022 | 225 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2862 | 0.050 |
Why?
|
Ultraviolet Rays | 2 | 2016 | 1100 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12092 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4584 | 0.050 |
Why?
|
Endometrium | 1 | 2004 | 407 | 0.050 |
Why?
|
Epithelial Cells | 2 | 2010 | 3692 | 0.050 |
Why?
|
Survival Analysis | 3 | 2020 | 10117 | 0.050 |
Why?
|
Calcium-Binding Proteins | 2 | 2017 | 1084 | 0.050 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2021 | 115 | 0.050 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2021 | 108 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10844 | 0.050 |
Why?
|
Endophenotypes | 1 | 2022 | 258 | 0.040 |
Why?
|
Fetal Blood | 2 | 2018 | 1361 | 0.040 |
Why?
|
Vitamin D Deficiency | 1 | 2010 | 1389 | 0.040 |
Why?
|
Mouth Mucosa | 1 | 2003 | 437 | 0.040 |
Why?
|
Molecular Sequence Data | 5 | 2009 | 17626 | 0.040 |
Why?
|
Nitrous Oxide | 1 | 2021 | 166 | 0.040 |
Why?
|
Menopause, Premature | 1 | 2021 | 124 | 0.040 |
Why?
|
China | 3 | 2012 | 2389 | 0.040 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 326 | 0.040 |
Why?
|
Signal Transduction | 4 | 2018 | 23629 | 0.040 |
Why?
|
Population Surveillance | 1 | 2010 | 2598 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4047 | 0.040 |
Why?
|
Epidemiologic Research Design | 1 | 2003 | 368 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2004 | 1758 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2013 | 3008 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2014 | 3438 | 0.040 |
Why?
|
Social Justice | 1 | 2024 | 486 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3794 | 0.040 |
Why?
|
United States National Aeronautics and Space Administration | 1 | 2019 | 16 | 0.040 |
Why?
|
Wheelchairs | 1 | 2019 | 78 | 0.040 |
Why?
|
Vitamins | 2 | 2005 | 1638 | 0.040 |
Why?
|
Melphalan | 1 | 2020 | 421 | 0.040 |
Why?
|
Binding Sites | 2 | 2006 | 6018 | 0.040 |
Why?
|
Mental Disorders | 1 | 2019 | 6876 | 0.040 |
Why?
|
Nitrosamines | 1 | 2019 | 88 | 0.040 |
Why?
|
Flavanones | 1 | 2019 | 75 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 861 | 0.040 |
Why?
|
Growth Disorders | 1 | 2023 | 635 | 0.040 |
Why?
|
Urinary Bladder Diseases | 1 | 2019 | 167 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 643 | 0.040 |
Why?
|
Nutrition Surveys | 2 | 2020 | 1736 | 0.040 |
Why?
|
Glioma | 1 | 2013 | 3526 | 0.040 |
Why?
|
Oxidants | 1 | 2019 | 168 | 0.040 |
Why?
|
Catechin | 1 | 2018 | 70 | 0.040 |
Why?
|
Women | 1 | 2020 | 226 | 0.040 |
Why?
|
Air Pollutants, Occupational | 1 | 2021 | 409 | 0.040 |
Why?
|
Fruit | 2 | 2019 | 1165 | 0.040 |
Why?
|
Group VI Phospholipases A2 | 1 | 2017 | 16 | 0.040 |
Why?
|
Vegetables | 2 | 2019 | 1200 | 0.040 |
Why?
|
Chromosome Mapping | 3 | 2012 | 4622 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2000 | 784 | 0.040 |
Why?
|
Spain | 2 | 2010 | 492 | 0.040 |
Why?
|
South Africa | 1 | 2023 | 1871 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2023 | 1078 | 0.040 |
Why?
|
Ketones | 1 | 2019 | 182 | 0.040 |
Why?
|
Placenta | 2 | 2017 | 1722 | 0.040 |
Why?
|
Isoflurane | 1 | 2021 | 384 | 0.040 |
Why?
|
Caloric Restriction | 1 | 2020 | 300 | 0.040 |
Why?
|
Bone Neoplasms | 2 | 2023 | 2565 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2009 | 2542 | 0.040 |
Why?
|
Uterus | 1 | 2021 | 661 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10776 | 0.040 |
Why?
|
Fasting | 1 | 2023 | 1610 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2277 | 0.040 |
Why?
|
Chronic Disease | 3 | 2019 | 9380 | 0.030 |
Why?
|
Dopamine | 1 | 2004 | 1617 | 0.030 |
Why?
|
Urinary Bladder | 2 | 2014 | 1160 | 0.030 |
Why?
|
New Hampshire | 2 | 2008 | 175 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2005 | 2353 | 0.030 |
Why?
|
Cotinine | 1 | 2017 | 206 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2024 | 1248 | 0.030 |
Why?
|
Personality Assessment | 1 | 2018 | 646 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5711 | 0.030 |
Why?
|
Heterozygote | 3 | 2009 | 2792 | 0.030 |
Why?
|
SEER Program | 1 | 2021 | 1474 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2017 | 1902 | 0.030 |
Why?
|
Genetic Drift | 1 | 2016 | 41 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 2 | 2008 | 89 | 0.030 |
Why?
|
Molecular Epidemiology | 2 | 1996 | 472 | 0.030 |
Why?
|
Registries | 3 | 2023 | 8378 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1998 | 458 | 0.030 |
Why?
|
Death Certificates | 1 | 2016 | 175 | 0.030 |
Why?
|
Psychology | 1 | 2018 | 355 | 0.030 |
Why?
|
Retroviridae | 1 | 1998 | 849 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2002 | 2363 | 0.030 |
Why?
|
Dietary Fats | 1 | 2003 | 2003 | 0.030 |
Why?
|
Interleukin-1beta | 2 | 2014 | 1020 | 0.030 |
Why?
|
Causality | 1 | 2022 | 1255 | 0.030 |
Why?
|
Mice | 6 | 2024 | 82004 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 1998 | 902 | 0.030 |
Why?
|
Mobility Limitation | 1 | 2019 | 409 | 0.030 |
Why?
|
Aspirin | 1 | 2007 | 3136 | 0.030 |
Why?
|
Hippocampus | 1 | 2008 | 3784 | 0.030 |
Why?
|
Health Occupations | 1 | 2016 | 225 | 0.030 |
Why?
|
Prejudice | 1 | 2019 | 574 | 0.030 |
Why?
|
Fatty Acids | 1 | 2022 | 1817 | 0.030 |
Why?
|
Feeding Behavior | 2 | 2019 | 3203 | 0.030 |
Why?
|
Carotid Arteries | 1 | 2019 | 943 | 0.030 |
Why?
|
Karyotyping | 1 | 2016 | 1173 | 0.030 |
Why?
|
Receptors, GABA-B | 1 | 2014 | 59 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2016 | 351 | 0.030 |
Why?
|
Protein Isoforms | 2 | 2012 | 1704 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2019 | 848 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2000 | 1118 | 0.030 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2014 | 57 | 0.030 |
Why?
|
Exons | 1 | 2000 | 2392 | 0.030 |
Why?
|
Homozygote | 2 | 2009 | 1779 | 0.030 |
Why?
|
Labor Unions | 1 | 2014 | 49 | 0.030 |
Why?
|
Chile | 1 | 2014 | 258 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2019 | 731 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2015 | 520 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1337 | 0.030 |
Why?
|
Nicotine | 1 | 2019 | 680 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
Prefrontal Cortex | 1 | 2004 | 2257 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14736 | 0.030 |
Why?
|
Prevalence | 3 | 2017 | 15868 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2021 | 862 | 0.030 |
Why?
|
Parkinson Disease | 1 | 2008 | 2893 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 2014 | 229 | 0.030 |
Why?
|
Alu Elements | 1 | 2014 | 116 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3324 | 0.030 |
Why?
|
Protein Binding | 3 | 2006 | 9346 | 0.030 |
Why?
|
Air | 1 | 2014 | 187 | 0.030 |
Why?
|
Carcinoma | 1 | 2004 | 2340 | 0.030 |
Why?
|
Weight Gain | 1 | 2023 | 2358 | 0.030 |
Why?
|
Sister Chromatid Exchange | 1 | 1992 | 60 | 0.030 |
Why?
|
Pigmentation | 1 | 2013 | 143 | 0.030 |
Why?
|
Genetic Pleiotropy | 1 | 2014 | 181 | 0.030 |
Why?
|
Glutathione S-Transferase pi | 2 | 2003 | 99 | 0.030 |
Why?
|
Michigan | 1 | 2013 | 341 | 0.030 |
Why?
|
Metals, Heavy | 1 | 2014 | 149 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2023 | 2911 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 1994 | 2950 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6132 | 0.030 |
Why?
|
Phylogeny | 1 | 2000 | 2842 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 1994 | 342 | 0.020 |
Why?
|
Algorithms | 2 | 2020 | 14154 | 0.020 |
Why?
|
Marital Status | 1 | 2013 | 426 | 0.020 |
Why?
|
Cholesterol | 2 | 2016 | 2912 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2014 | 332 | 0.020 |
Why?
|
tau Proteins | 1 | 2022 | 2142 | 0.020 |
Why?
|
Dioxygenases | 1 | 2014 | 351 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2715 | 0.020 |
Why?
|
Time Factors | 4 | 2019 | 40267 | 0.020 |
Why?
|
Sunlight | 1 | 2013 | 337 | 0.020 |
Why?
|
Diabetes Mellitus | 2 | 2025 | 5890 | 0.020 |
Why?
|
Computer Simulation | 1 | 2005 | 6277 | 0.020 |
Why?
|
Waist Circumference | 1 | 2015 | 935 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2445 | 0.020 |
Why?
|
Telomeric Repeat Binding Protein 1 | 1 | 2010 | 7 | 0.020 |
Why?
|
Hair Color | 1 | 2011 | 131 | 0.020 |
Why?
|
Contraception | 1 | 2014 | 362 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2008 | 5422 | 0.020 |
Why?
|
Religion | 1 | 2014 | 377 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2014 | 704 | 0.020 |
Why?
|
Stroke | 1 | 2013 | 9742 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2588 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1119 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1748 | 0.020 |
Why?
|
Foster Home Care | 1 | 2011 | 140 | 0.020 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2014 | 705 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4545 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2961 | 0.020 |
Why?
|
Selection Bias | 1 | 2011 | 360 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 1998 | 6228 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 805 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3587 | 0.020 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2009 | 56 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 3909 | 0.020 |
Why?
|
Finland | 1 | 2010 | 610 | 0.020 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2008 | 68 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2012 | 737 | 0.020 |
Why?
|
Transcription Factors | 3 | 2003 | 12166 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2038 | 0.020 |
Why?
|
Gestational Age | 1 | 2017 | 3615 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3092 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2014 | 1184 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4630 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2010 | 344 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 1994 | 997 | 0.020 |
Why?
|
Microdissection | 1 | 2008 | 151 | 0.020 |
Why?
|
Camptothecin | 1 | 2012 | 593 | 0.020 |
Why?
|
Comorbidity | 1 | 2023 | 10588 | 0.020 |
Why?
|
Sample Size | 1 | 2011 | 848 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2013 | 1627 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2010 | 962 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2010 | 781 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 217 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5102 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1585 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11117 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2009 | 213 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3474 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1900 | 0.020 |
Why?
|
India | 1 | 2014 | 2324 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2009 | 300 | 0.020 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2009 | 203 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3905 | 0.020 |
Why?
|
Lipids | 1 | 2018 | 3344 | 0.020 |
Why?
|
Liver | 2 | 2012 | 7570 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 1994 | 984 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2014 | 1894 | 0.020 |
Why?
|
Electroretinography | 1 | 2009 | 524 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2010 | 542 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1753 | 0.020 |
Why?
|
Seasons | 1 | 1992 | 1526 | 0.020 |
Why?
|
Chromatin | 1 | 2018 | 2967 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2009 | 856 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2010 | 81768 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4834 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 1992 | 1463 | 0.020 |
Why?
|
Pancreatic Ducts | 1 | 2008 | 330 | 0.020 |
Why?
|
Glycine | 1 | 2009 | 672 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 129 | 0.020 |
Why?
|
Public Health Nursing | 1 | 2005 | 14 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6238 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1428 | 0.020 |
Why?
|
Models, Statistical | 2 | 2015 | 5099 | 0.020 |
Why?
|
Veterans | 1 | 2018 | 2672 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2017 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6541 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1643 | 0.010 |
Why?
|
Lasers | 1 | 2008 | 952 | 0.010 |
Why?
|
Fats, Unsaturated | 1 | 2003 | 21 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2661 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2014 | 3230 | 0.010 |
Why?
|
DNA Ligases | 1 | 2003 | 81 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1135 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2009 | 1445 | 0.010 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2003 | 46 | 0.010 |
Why?
|
Epitopes | 1 | 2010 | 2525 | 0.010 |
Why?
|
Mice, SCID | 1 | 2008 | 2632 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2708 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8326 | 0.010 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2002 | 27 | 0.010 |
Why?
|
Violence | 1 | 2009 | 938 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22355 | 0.010 |
Why?
|
Verbal Learning | 1 | 2005 | 465 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3520 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1998 | 19019 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2971 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4357 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 1994 | 3811 | 0.010 |
Why?
|
International Cooperation | 1 | 2009 | 1438 | 0.010 |
Why?
|
Computational Biology | 1 | 2014 | 3541 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3859 | 0.010 |
Why?
|
Proline | 1 | 2003 | 455 | 0.010 |
Why?
|
TATA Box | 1 | 2001 | 127 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15939 | 0.010 |
Why?
|
Body Composition | 1 | 2010 | 2461 | 0.010 |
Why?
|
Methyltransferases | 1 | 2003 | 373 | 0.010 |
Why?
|
Family | 1 | 2010 | 3208 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 2006 | 7599 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13646 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20766 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2009 | 6034 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4301 | 0.010 |
Why?
|
Memory, Short-Term | 1 | 2005 | 1010 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3412 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 1998 | 69 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13499 | 0.010 |
Why?
|
Histone Chaperones | 1 | 1998 | 85 | 0.010 |
Why?
|
Introns | 1 | 2000 | 968 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8072 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27452 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36849 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12801 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2003 | 65365 | 0.010 |
Why?
|
Internet | 1 | 2009 | 3107 | 0.010 |
Why?
|
3T3 Cells | 1 | 1998 | 1086 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2001 | 1748 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2011 | 4429 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1998 | 1163 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1992 | 11914 | 0.010 |
Why?
|
France | 1 | 1996 | 497 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2006 | 3334 | 0.010 |
Why?
|
Asbestosis | 1 | 1994 | 81 | 0.010 |
Why?
|
Silicosis | 1 | 1994 | 48 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 1995 | 326 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1998 | 13425 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2750 | 0.010 |
Why?
|
Health Personnel | 1 | 2007 | 3381 | 0.010 |
Why?
|
Mass Screening | 1 | 2009 | 5451 | 0.010 |
Why?
|
Receptor, erbB-2 | 2 | 1994 | 2588 | 0.010 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 1998 | 731 | 0.010 |
Why?
|
Growth Substances | 1 | 1995 | 761 | 0.010 |
Why?
|
Asbestos | 1 | 1994 | 251 | 0.010 |
Why?
|
Mammography | 1 | 2003 | 2434 | 0.010 |
Why?
|
Carcinoma, Small Cell | 1 | 1994 | 420 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 1998 | 3779 | 0.010 |
Why?
|
Immunoblotting | 1 | 1994 | 1647 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1995 | 947 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1992 | 1216 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1994 | 1094 | 0.000 |
Why?
|
Lymphatic Metastasis | 1 | 1994 | 2924 | 0.000 |
Why?
|
Myocardium | 1 | 1998 | 4788 | 0.000 |
Why?
|
Protein Conformation | 1 | 1992 | 3957 | 0.000 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1996 | 2331 | 0.000 |
Why?
|
Peptides | 1 | 1992 | 4352 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1998 | 11659 | 0.000 |
Why?
|